
Black Belt Therapeutics spins out of Tusk concurrent with acquisition by Roche
Executive Summary
Concurrent with Roche’s acquisition of Tusk Therapeutics Ltd., Tusk spun out a new company called Black Belt Therapeutics to continue pursuing oncology candidates in Tusk’s pipeline.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Divestiture/Spin-Out
- Intra-Biotech Deal
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice